Case Study: Reducing product loss | Cost-efficiency

Claus Exenberger - Single Use Support

Claus Exenberger

June 8, 2022

Table of contents

Show

Biopharmaceutical companies have largely accepted a certain level of product loss when managing drug substances in single-use systems - unaware that solutions exist to streamline process steps and dramatically diminish product loss . The breaking of single-use bags in turn means loss of very valuble drug substances

A global biotechnology company produces different drug substances of highly valuables monoclonal antibodies (mABs). The company experienced a product loss rate between 0.5% and 5% due to the sensitivity of single-use bioprocess containers at sub-zero temperatures. Therefore, the goal was to reduce the current product loss below 0.5%.

This case study discloses how the implementation of RoSS® technologies from Single Use Support had an impact on the product loss during trials of hundreds of single-use bags. 

You will be surprised of the cost savings due to reduced product loss.

Case Study - Reducing Product Loss | Cost-Efficiency

A multinational CDMO (contract development and manufacturing organization) with USD 5 billion turnover develops and manufactures pharmaceuticals that are outsourced from biotechnology companies. Based on requirements the CDMO takes full responsibility of manufacturing of drug substance, cell & gene therapies and more within the contraced period of time.
Claus Exenberger - Single Use Support

Claus Exenberger

Product Line Management

Claus Exenberger is Product Line Manager at Single Use Support. As product owner of the RoSS shell, the secondary packaging of single-use bags, Claus and his team develops further non-sterile products to advance handling of single-use bags for the biopharmaceutical industry. With his working experience of 5+ years at Single Use Support he is expert in the protection of all available single-use bioprocess containers. His proximity to customers helps connect his process-oriented approach with the technical development of products.

More from Claus Exenberger

Monoclonal Antibodies

Safe handling of monoclonal antibodies: Best practices

Monoclonal antibodies bring along some special requirements in terms of safe handling. In this article, we will discover what these requirements are, and how they can be met.

Claus Exenberger - Single Use Support

Claus Exenberger

February 7, 2024

Single-use Technology

Primary and secondary packaging of drug substances

Throughout the manufacturing process of drug substances, the liquids must be transferred frequently, such as during the upstream and downstream processing. Safe packaging of large volume substances is of high necessity in each step. Protection is ensured by appropriate primary and secondary packaging. This article will provide an overview of the different types of primary and secondary packaging materials, which are used specifically for safe handling of drug substance. 

Claus Exenberger - Single Use Support

Claus Exenberger

March 14, 2023

Read more about Single-use Consumables

Single-use Consumables

Go with The Flow: How Sustainable is the Trend Toward Single-use Systems?

Single-use systems support novel approaches to aseptic fluid management and aseptic liquid transfer. However, regarding the sustainability of single-use systems, there are still concerns within the scientific community. BioPharm International sat down with Single Use Support to address these apprehensions and discuss the future of single-use systems in biopharma. 

Khalil Essani - Single Use Support

Khalil Essani

February 5, 2024

Single-use Consumables

Bubble point test: Purpose & Procedure

Among the possible filter integrity testing methods, the bubble point test belongs to the most frequent ones. Therefore, this article will describe the process along with its applications, benefits and limitations, and its automation.

1640281789974

David Seifert

March 20, 2024

Single-use Consumables

Annex 1: All you need to know

Annex 1 is a fundamental framework for the production of sterile medicinal goods. This article will provide an overview of the concept, its history, contents, challenges, and perspectives.

michael-muehlegger

Michael Mühlegger

March 20, 2024

Single-use Consumables

Annex 1 and the PUPSIT requirement

Annex 1 and PUPSIT meant significant changes in the pharmaceutical sector. In this article, we will illustrate the focus areas of Annex 1 and will discuss main aspects of PUPSIT.

Khalil Essani - Single Use Support

Khalil Essani

March 13, 2024